XML 61 R42.htm IDEA: XBRL DOCUMENT v3.24.0.1
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 30, 2023
Share-based Payment Arrangement [Abstract]  
Schedule of Assumptions Used in Estimating Fair Value of Each Option Grant The fair value of each option grant made as of December 30, 2023, December 31, 2022, and December 25, 2021 was estimated using the following assumptions:

​

​

​

​

​

​

​

​

​

​

​

​

    

December 30,

​

December 31,

​

December 25,

​

​

2023

​

2022

​

2021

Expected volatility

 

31.97

%  

​

32.36

%  

​

33.01

%

Risk-free interest rate

 

4.21

%  

​

3.75

%  

​

1.26

%

Expected life from vesting date

 

5.4 yrs

 

​

5.4 yrs

 

​

4.0 yrs

​

Dividend yield

 

0.87

%  

​

1.10

%  

​

1.20

%

Summary of Activity of Stock Plans

​

​

​

​

​

​

​

​

​

​

​

​

    

December 30,

​

December 31,

​

December 25,

​

​

2023

​

2022

​

2021

Expected volatility

 

31.97

%  

​

32.36

%  

​

33.01

%

Risk-free interest rate

 

4.21

%  

​

3.75

%  

​

1.26

%

Expected life from vesting date

 

5.4 yrs

 

​

5.4 yrs

 

​

4.0 yrs

​

Dividend yield

 

0.87

%  

​

1.10

%  

​

1.20

%

​

The following is a summary of the stock option activity during the fiscal years ended December 30, 2023, December 31, 2022, and December 25, 2021:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted

​

​

​

​

​

​

​

Weighted

​

Average

​

​

​

​

​

​

​

Average

​

Remaining

​

Aggregate

​

​

Number of

​

Exercise

​

Contractual

​

Intrinsic

​

    

Shares

    

Price

    

Term

    

Value

Outstanding as of December 31, 2022

 

195,690

​

$

214.62

 

  

 

​

  

Granted

 

43,340

​

 

226.55

 

  

 

​

  

Exercised

 

(39,055)

​

 

155.24

 

  

 

​

  

Forfeited

 

(18,445)

​

 

307.81

 

  

 

​

  

Outstanding as of December 30, 2023

 

181,530

​

$

220.77

 

7.99

​

$

5,992

Options vested or expected to vest as of December 30, 2023

 

178,820

​

$

220.31

 

7.96

​

 

5,975

Options exercisable as of December 30, 2023

 

116,545

​

$

203.78

 

7.13

​

 

5,576

The weighted average per share fair value of options granted during the fiscal year ended December 31, 2023 was $72.60.

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted

​

​

​

​

​

​

​

Weighted

​

Average

​

​

​

​

​

​

​

Average

​

Remaining

​

Aggregate

​

​

Number of

​

Exercise

​

Contractual

​

Intrinsic

​

    

Shares

    

Price

    

Term

    

Value

Outstanding as of December 25, 2021

 

276,464

​

$

164.48

 

  

 

​

  

Granted

 

40,564

​

 

332.63

 

  

 

​

  

Exercised

 

(121,163)

​

 

139.89

 

  

 

​

  

Forfeited

 

(175)

​

 

104.47

 

  

 

​

  

Outstanding as of December 31, 2022

 

195,690

​

$

214.62

 

7.53

​

$

22,644

Options vested or expected to vest as of December 31, 2022

 

189,267

​

$

212.69

 

7.48

​

 

22,261

Options exercisable as of December 31, 2022

 

90,556

​

$

172.08

 

6.40

​

 

14,276

The weighted average per share fair value of options granted during the fiscal year ended December 31, 2022 was $104.01.

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted

​

​

​

​

​

​

​

Weighted

​

Average

​

​

​

​

​

​

​

Average

​

Remaining

​

Aggregate

​

​

Number of

​

Exercise

​

Contractual

​

Intrinsic

​

    

Shares

    

Price

    

Term

    

Value

Outstanding as of December 26, 2020

 

399,565

​

$

141.79

 

  

 

​

  

Granted

 

47,223

​

 

252.89

 

  

 

​

  

Exercised

 

(169,908)

​

 

135.76

 

  

 

​

  

Forfeited

 

(416)

​

 

132.84

 

  

 

​

  

Outstanding as of December 25, 2021

 

276,464

​

$

164.48

 

5.88

​

$

22,586

Options vested or expected to vest as of December 25, 2021

 

268,338

​

$

163.42

 

5.80

​

 

22,188

Options exercisable as of December 25, 2021

 

154,860

​

$

142.15

 

4.00

​

 

15,896

The weighted average per share fair value of options granted during the fiscal year ended December 25, 2021 was $67.81.

Schedule of Non-Vested Stock and Restricted Stock Units During the fiscal years ended December 30, 2023, December 31, 2022, and December 25, 2021, the Company granted restricted stock units to directors and certain management employees as follows (which are not included in the above stock plan activity tables):

​

​

​

​

​

​

​

​

​

​

​

​

    

Fiscal Year Ended

​

​

December 30,

​

December 31,

​

December 25,

​

​

2023

    

2022

    

2021

Restricted stock units granted

 

​

67,723

 

​

60,901

 

​

216,971

Weighted‑average per share price on grant date

​

$

233.96

​

$

313.75

​

$

236.28

Recognized compensation expense

​

$

22,478

​

$

22,664

​

$

16,147

Share-based Payment Arrangement, Performance Shares, Outstanding Activity

During the fiscal years ended December 30, 2023, December 31, 2022, and December 25, 2021, the Company granted PSU awards as follows (which are not included in the above stock plan activity tables):

​

​

​

​

​

​

​

​

​

​

​

    

Fiscal Year Ended

​

​

December 30,

​

December 31,

​

December 25,

​

​

2023

    

2022

    

2021

Shares granted

 

​

38,201

 

​

33,736

 

​

41,060

Weighted‑average per share price on grant date

​

$

299.20

​

$

215.15

​

$

230.40

Recognized compensation expense

​

$

13,054

​

$

16,066

​

$

10,035